ARTICLE | Clinical News
Avodart dutasteride regulatory update
January 31, 2011 8:00 AM UTC
FDA issued a complete response for an sNDA from GlaxoSmithKline for Avodart dutasteride to reduce the risk of prostate cancer in men at increased risk of the disease. GSK would not disclose the conten...